>
$11 Trillion Quietly Moved - Americans Will Freeze & Obey When Market Collapse Hits : Chase Hughes
Econ 101 - 2026 Early Economic Forecast
Buy'r breaks the Blackrock monopoly- How the corporate club controls America
An AI Expert Warning: 6 People Are (Quietly) Deciding Humanity's Future! We Must Act Now!
Build a Greenhouse HEATER that Lasts 10-15 DAYS!
Look at the genius idea he came up with using this tank that nobody wanted
Latest Comet 3I Atlas Anomolies Like the Impossible 600,000 Mile Long Sunward Tail
Tesla Just Opened Its Biggest Supercharger Station Ever--And It's Powered By Solar And Batteries
Your body already knows how to regrow limbs. We just haven't figured out how to turn it on yet.
We've wiretapped the gut-brain hotline to decode signals driving disease
3D-printable concrete alternative hardens in three days, not four weeks
Could satellite-beaming planes and airships make SpaceX's Starlink obsolete?

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.